Benlysta (belimumab)

pCPA File Number: 20721
Negotiation Status:
Negotiations were not pursued
Indication(s):
Systemic lupus erythematosus
Sponsor/Manufacturer:
GlaxoSmithKline Inc.
CDA-AMC Project Number:
SR0251-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: